Menu
News
Ibogaine
Ketamine
LSD
MDMA
Psilocybin
Resources
Research Hubs
Studies and Reports
Provider Directory
Terminology
Opinion
Events
About Us
LSD
Take-Home LSD: MindBio Begins Phase 2B Microdosing Clinical Trial of MB22001
March 25, 2024
Optimi Health Receives Regulatory Approval to Export to Australia
June 3, 2024
Lykos Appoints Finance Veteran Scott Giacobello to Board of Directors
May 31, 2024
DEA: MIRA-55 Marijuana Analog Not a Controlled Substance
May 29, 2024
Psilocybin Clinical Trial for Mental-Health Workers Approved in Canada
May 24, 2024
«
‹
6
7
8
9
›
»